Carl Zeiss Meditec AG (ETR:AFX) Receives €81.19 Average Target Price from Analysts

Shares of Carl Zeiss Meditec AG (ETR:AFX) have been given an average recommendation of “Hold” by the eight ratings firms that are covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, five have given a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is €84.06 ($97.75).

AFX has been the topic of several recent research reports. Berenberg Bank set a €93.00 ($108.14) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Wednesday, July 17th. Nord/LB set a €92.00 ($106.98) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Wednesday, May 8th. HSBC set a €98.00 ($113.95) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Wednesday. Independent Research set a €88.00 ($102.33) target price on shares of Carl Zeiss Meditec and gave the stock a “sell” rating in a research note on Wednesday, July 17th. Finally, Deutsche Bank set a €89.00 ($103.49) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Monday, August 12th.

AFX traded up €1.40 ($1.63) on Friday, hitting €99.30 ($115.47). 106,762 shares of the company’s stock were exchanged, compared to its average volume of 94,405. Carl Zeiss Meditec has a fifty-two week low of €60.25 ($70.06) and a fifty-two week high of €104.30 ($121.28). The company has a current ratio of 4.11, a quick ratio of 3.09 and a debt-to-equity ratio of 4.55. The firm has a 50-day moving average price of €93.78 and a 200-day moving average price of €84.80. The stock has a market cap of $8.88 billion and a price-to-earnings ratio of 69.25.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Featured Article: Google Finance Portfolio

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.